T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma
D Maggioni, L Pignataro, W Garavello - Oncoimmunology, 2017 - Taylor & Francis
Head and neck squamous cell carcinoma (HNSCC) is one of the most diffused cancer types,
characterized by a high reoccurrence rate, mainly due to the inability of current therapeutic …
characterized by a high reoccurrence rate, mainly due to the inability of current therapeutic …
Immune alterations and immunotherapy prospects in head and neck cancer
V Varilla, J Atienza, CA Dasanu - Expert opinion on biological …, 2013 - Taylor & Francis
Introduction: Several literature sources have suggested that subjects with head and neck
squamous cell carcinoma (HNSCC) display significant abnormalities of immunocompetent …
squamous cell carcinoma (HNSCC) display significant abnormalities of immunocompetent …
High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer
Ö Met, E Balslev, H Flyger, IM Svane - Breast cancer research and …, 2011 - Springer
As pre-existent immunity might be a reflection of an emerging anticancer response, the
demonstration of spontaneous T-cell responses against tumor associated antigens (TAAs) in …
demonstration of spontaneous T-cell responses against tumor associated antigens (TAAs) in …
Tumor vaccines in 2010: need for integration
D Koos, SF Josephs, DT Alexandrescu, RCF Chan… - Cellular …, 2010 - Elsevier
Induction of tumor-specific immunity is an attractive approach to cancer therapy, however to
date every major pivotal trial has resulted in failure. While the phenomena of tumor …
date every major pivotal trial has resulted in failure. While the phenomena of tumor …
[HTML][HTML] Intratumoral Convergence of the TCR Repertoires of Effector and Foxp3+ CD4+ T cells
M Kuczma, M Kopij, I Pawlikowska, CY Wang… - PLoS …, 2010 - journals.plos.org
The presence of Foxp3+ regulatory CD4+ T cells in tumor lesions is considered one of the
major causes of ineffective immune response in cancer. It is not clear whether intratumoral …
major causes of ineffective immune response in cancer. It is not clear whether intratumoral …
p53 肽在肿瘤免疫治疗中的研究进展
单士刚， 包永芬， 陈贤均 - 肿瘤学杂志, 2011 - cqvip.com
体内外研究证实wtp53 肽段可诱导特异性的CD8+ T 细胞和CD4+ T 细胞, 因此, wtp53
肽在肿瘤免疫治疗中得到广泛应用, 并且, 一些表位疫苗的抗肿瘤免疫治疗已进入Ⅰ, Ⅱ …
肽在肿瘤免疫治疗中得到广泛应用, 并且, 一些表位疫苗的抗肿瘤免疫治疗已进入Ⅰ, Ⅱ …
Immunopathology as a Basis for Immunotherapy of Head and Neck Squamous Cell Carcinoma
X Qian, TK Hoffmann, AM Kaufmann… - … Cancer Immunotherapy for …, 2020 - Springer
Immunologic strategies to treat head and neck squamous cell carcinoma (HNSCC) have
recently attracted new interest with the introduction of immunotherapy like checkpoint …
recently attracted new interest with the introduction of immunotherapy like checkpoint …
Qualitative und quantitative Analyse und Vergleich von Tumorantigenen und HLA Klasse I-Liganden in Primärtumoren und Metastasen des Nierenzellkarzinoms
JS Stickel - 2011 - tobias-lib.ub.uni-tuebingen.de
In den letzten Jahren, wurden zahlreiche Fortschritte auf dem Weg zu einer peptidbasierten
Immuntherapie des metastasierten Nierenzellkarzinoms errungen. Dennoch ist bis heute …
Immuntherapie des metastasierten Nierenzellkarzinoms errungen. Dennoch ist bis heute …
Immunopathology of Head and Neck Tumors and Immunotherapy of Squamous Cell Carcinoma
X Qian, AM Kaufmann, AE Albers - Cancer Immunology: Cancer …, 2015 - Springer
The competent immune system controls disease effectively due to induction, function, and
regulation of effector lymphocytes. Although immunosurveillance has been induced by …
regulation of effector lymphocytes. Although immunosurveillance has been induced by …